Concepedia

Michael C. Gignac

MC

Statistics

Publications

7

Citations

380

H-Index

7

Active since

2014

Affiliations

University of Victoria(Current)

Center for Cancer Research

Purdue University West Lafayette

Michael C. Gignac is an author at University of Victoria specializing in drug discovery, ligand binding, and medicinal chemistry.

ORCID

Publications per year

2014–2022

7

Publications

7

Chromodomain Antagonists That Target the Polycomb-Group Methyllysine Reader Protein Chromobox Homolog 7 (CBX7)

Chakravarthi Simhadri, Kevin D. Daze, Sarah F. Douglas et al. · Journal of Medicinal Chemistry · 2014 · 108 citations · Full text

, , +17

Optimization of Ligands Using Focused DNA-Encoded Libraries To Develop a Selective, Cell-Permeable CBX8 Chromodomain Inhibitor

Sijie Wang, Kyle E. Denton, Kathryn Hobbs et al. · ACS Chemical Biology · 2019 · 84 citations · Full text

, , +17

Robustness of In Vitro Selection Assays of DNA-Encoded Peptidomimetic Ligands to CBX7 and CBX8

Kyle E. Denton, Sijie Wang, Michael C. Gignac et al. · SLAS DISCOVERY · 2018 · 57 citations · Full text

, , +17

Selective Inhibition of CBX6: A Methyllysine Reader Protein in the Polycomb Family

Natalia Milosevich, Michael C. Gignac, James McFarlane et al. · ACS Medicinal Chemistry Letters · 2015 · 54 citations · Full text

, , +16

CLIC-01: Manufacture and distribution of non-cryopreserved CAR-T cells for patients with CD19 positive hematologic malignancies

Natasha Kekre, Kevin A. Hay, John R. Webb et al. · Frontiers in Immunology · 2022 · 30 citations · Full text

, , +17

1–5 of 7